Latest Biologic Stories
SAN DIEGO, March 2, 2015 /PRNewswire/ -- Pfenex Inc.
ROCKVILLE, Md., March 2, 2015 /PRNewswire/ -- Synthetic Biologics, Inc.
ALEXANDRIA, Va., Feb.
SHANGHAI, Feb. 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
SAN DIEGO, Feb. 27, 2015 /PRNewswire/ -- Pfenex Inc.
Dermatology offices, psoriasis patients encouraged to join the research efforts PORTLAND, Ore., Feb.
Product is the first approved monoclonal antibody to aid in the treatment of canine B-cell lymphoma KANSAS CITY, Kan., Feb. 24, 2015 /PRNewswire/ -- Aratana Therapeutics, Inc.
New research finds only biosimilars for blockbuster biologics are likely viable ST. PAUL, Minn., Feb.
DUBLIN, Feb .20, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/4rqtv7/global)
-- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn's disease and ulcerative colitis BARCELONA and MADRID, Spain, Feb.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.